Completed PHASE2 INTERVENTIONAL 4-arm NCT00246025

A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery.

A Randomised, Parallel-group, Double-blind, Placebo Controlled Study to Investigate the Efficacy and Safety of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Knee Replacement Surgery

Sponsor: Boehringer Ingelheim

Conditions Arthroplasty, Replacement, Knee Venous Thrombosis

Interventions Dabigatran Etexilate Dabigatran etexilate placebo

Updated 5 times since 2017 Last updated: Jun 3, 2014 Started: Oct 31, 2005 Primary completion: Jun 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Arthroplasty, Replacement, Knee and Venous Thrombosis, this trial is completed. The trial is conducted by Boehringer Ingelheim and has accumulated 5 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Oct 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Boehringer Ingelheim

Data source: Boehringer Ingelheim

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Eniwa, Hokkaido, Japan , Fukuoka, Fukuoka, Japan , Hachioji, Tokyo, Japan , Hirosaki, Aomori, Japan , Hiroshima, Hiroshima, Japan , Iida, Nagano, Japan , Izumisano, Osaka, Japan , Izunokuni,Shizuoka, Japan , Kagoshima, Kagoshima, Japan , Kawasaki, Kanagawa, Japan and 21 more locations